- Supported exchanges /
- TWO /
- 6499.TWO
Medeon Biodesign (6499 TWO) stock market data APIs
Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in Taiwan and the United States. The company focuses on developing devices for minimally invasive surgeries, such as Duett, a vascular graft system; ClickClean, a solution to view throughout laparoscopic surgeries; AbClose to prevent port site herniation caused by improper closure; UroCross, an expander system; PUMA, a solution to treat orthopedic extremity injuries; and Cross-Seal, a large-bore closure device. It is involved in medical device contract manufacturing, equity investment and commerce of medical devices, manufacturing and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is headquartered in Taipei, Taiwan.
Medeon Biodesign Financial Data Overview
| 44.9 | |
| 45.25 | |
| - | |
| 45.3 | |
| 44.7 | |
| 39.45-55 | |
| 4 137 M | |
| 92 144 K | |
| 212 M | |
| -1.42 | |
| 0.707 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Medeon Biodesign Fundamental Data is available in our Financial Data APIs
- Net Revenue 212 M
- EBITDA -840 478 976
- Earnings Per Share -12.88
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Medeon Biodesign Earnings via APIs
- Latest Release 2022-11-08
- EPS/Forecast NaN
Get Medeon Biodesign End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
